February 7th 2025
The association’s Executive Director Georges Benjamin, MD, offers some commentary as to why they have concerns around him as Health and Human Services Secretary.
Charting the Path to Precision Diagnosis: Detection and Treatment Approaches for Oncogenic Mutations in NSCLC
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Surv.AI Says: Real-World Insights Into the Journey for Patients With Pulmonary Arterial Hypertension
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Addressing Racial Disparities in Multiple Myeloma: Forging a Path Towards Health Equity in Clinical Trials and Everyday Practice
View More
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
Influenza Vaccine During Pregnancy May Protect Newborn Infants
May 31st 2016The number of expecting mothers who opt for annual vaccination for influenza during pregnancy remains relatively low; however, the results of a new study suggest this may be changing—and that there are obvious benefits for immunization for newborns.
Read More
Global Influenza Surveillance Program Shows Promising Results
May 27th 2016A program designed to improve the quality of influenza surveillance capabilities in 39 countries from around the globe through partnership with the Centers for Disease Control and Prevention (CDC) seems to have resulted in remarkable progress on all six of the assessed metrics, and even led to improvements in the surveillance of other pathogens, according to the results of a recent study.
Read More
Challenging the Gold Standard for Evaluating Influenza Vaccines
May 26th 2016The level of hemagglutination inhibition (HAI) used as the traditional gold standard for evaluating influenza vaccines in the United States and European Union may not actually be the best predictor of protection from influenza virus-induced disease.
Read More
Asymptomatic Influenza Infection Rates Deserve More Attention
May 20th 2016The consequences of not understanding the actual rate of asymptomatic influenza infection can be grave, as influenza virus infection of the respiratory tract has been shown to result in severe disease and complications, including pneumonia, shock, renal failure, encephalopathy, and multiorgan dysfunction, which can be lethal.
Read More
The CDC Epidemic Intelligence Service Takes Aim at Tuberculosis at Recent Conference
May 13th 2016Officers of the CDC’s Epidemic Intelligence Service (EIS) presented recent research on tuberculosis (TB) on May 3 in a session at the 65th Annual Epidemic Intelligence Service Conference in Atlanta, Georgia. A summary of the presentations is included in this article.
Read More
Recent Influenza Research by the CDC Epidemic Intelligence Service
May 11th 2016Public health leaders have serious concerns about influenza, according to Dan Jernigan, MD, MPH, director of the Centers for Disease Control and Prevention (CDC) Influenza Division during a session on influenza on May 2nd during the 65th Annual Epidemic Intelligence Service (EIS) Conference in Atlanta, Georgia.
Read More
Research on Universal Vaccine for Influenza Uncovers More Than Just Financial Limitations
May 2nd 2016A recent review article on the status of influenza vaccines, their short-comings, and ways to improve them suggests the potential for significant improvements in the performance of future influenza vaccines.
Read More
Study Calls for Alternatives to Egg-Based Manufacturing of Influenza Vaccines
April 28th 2016Because certain viral sub-types are associated with higher rates of morbidity and mortality than others, efforts to improve the effectiveness of influenza vaccines remain an important focus of future research.
Read More
Is There a Legionnaire's Epidemic Brewing in the United States?
April 25th 2016The impact of the water crisis in Flint, Michigan now includes an infectious disease component—namely, an outbreak of Legionnaire’s disease—and it has sparked a debate among health officials and infectious disease experts.
Read More
hMPV: Is This Relatively New Paramyxovirus Cause for Concern?
March 28th 2016Human metapneumovirus (hMPV), of the paramyxovirus family, was discovered in 2001. hMPV can affect people of all ages, however, older adults, children and individuals with weak immune systems are at highest risk of contracting the virus.
Read More
Using Infant's Heart Rate as Alternative Marker to Determine Respiratory Infection Severity
March 11th 2016Because ARIs are common in infants and can negatively impact their health beyond infancy, simple and objective measures of the level of severity are necessary for clinical management decisions.
Read More
New Study Finds a Link between a Person's Ethnicity and Response to the Influenza Vaccine
March 1st 2016Researchers from the Dana-Farber Cancer Institute in Boston, MA have, for the first time, identified a link between a person's genetic make-up, as well as their ethnic background, and their response to influenza vaccine.
Read More